Global Biosimilar Testing Service Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Biosimilar Testing Service Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Biosimilar Testing Service Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Pharmacokinetic Assay
  • 1.4.3 Tiered Immunogenicity Testing
  • 1.4.4 Others
• 1.5 Market by Application
  • 1.5.1 Global Biosimilar Testing Service Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Pharmaceutical Companies
  • 1.5.4 Others
• 1.6 Coronavirus Disease 2019 (Covid-19): Biosimilar Testing Service Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Biosimilar Testing Service Industry
    • 1.6.1.1 Biosimilar Testing Service Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Biosimilar Testing Service Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Biosimilar Testing Service Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Biosimilar Testing Service Market Perspective (2015-2026)
• 2.2 Biosimilar Testing Service Growth Trends by Regions
  • 2.2.1 Biosimilar Testing Service Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Biosimilar Testing Service Historic Market Share by Regions (2015-2020)
  • 2.2.3 Biosimilar Testing Service Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Biosimilar Testing Service Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Biosimilar Testing Service Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Biosimilar Testing Service Players by Market Size
  • 3.1.1 Global Top Biosimilar Testing Service Players by Revenue (2015-2020)
  • 3.1.2 Global Biosimilar Testing Service Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Biosimilar Testing Service Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Biosimilar Testing Service Market Concentration Ratio
  • 3.2.1 Global Biosimilar Testing Service Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Biosimilar Testing Service Revenue in 2019
• 3.3 Biosimilar Testing Service Key Players Head office and Area Served
• 3.4 Key Players Biosimilar Testing Service Product Solution and Service
• 3.5 Date of Enter into Biosimilar Testing Service Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Biosimilar Testing Service Historic Market Size by Type (2015-2020)
• 4.2 Global Biosimilar Testing Service Forecasted Market Size by Type (2021-2026)

5 Biosimilar Testing Service Breakdown Data by Application (2015-2026)

• 5.1 Global Biosimilar Testing Service Market Size by Application (2015-2020)
• 5.2 Global Biosimilar Testing Service Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Biosimilar Testing Service Market Size (2015-2020)
• 6.2 Biosimilar Testing Service Key Players in North America (2019-2020)
• 6.3 North America Biosimilar Testing Service Market Size by Type (2015-2020)
• 6.4 North America Biosimilar Testing Service Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Biosimilar Testing Service Market Size (2015-2020)
• 7.2 Biosimilar Testing Service Key Players in Europe (2019-2020)
• 7.3 Europe Biosimilar Testing Service Market Size by Type (2015-2020)
• 7.4 Europe Biosimilar Testing Service Market Size by Application (2015-2020)

8 China

• 8.1 China Biosimilar Testing Service Market Size (2015-2020)
• 8.2 Biosimilar Testing Service Key Players in China (2019-2020)
• 8.3 China Biosimilar Testing Service Market Size by Type (2015-2020)
• 8.4 China Biosimilar Testing Service Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Biosimilar Testing Service Market Size (2015-2020)
• 9.2 Biosimilar Testing Service Key Players in Japan (2019-2020)
• 9.3 Japan Biosimilar Testing Service Market Size by Type (2015-2020)
• 9.4 Japan Biosimilar Testing Service Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Biosimilar Testing Service Market Size (2015-2020)
• 10.2 Biosimilar Testing Service Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Biosimilar Testing Service Market Size by Type (2015-2020)
• 10.4 Southeast Asia Biosimilar Testing Service Market Size by Application (2015-2020)

11 India

• 11.1 India Biosimilar Testing Service Market Size (2015-2020)
• 11.2 Biosimilar Testing Service Key Players in India (2019-2020)
• 11.3 India Biosimilar Testing Service Market Size by Type (2015-2020)
• 11.4 India Biosimilar Testing Service Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Biosimilar Testing Service Market Size (2015-2020)
• 12.2 Biosimilar Testing Service Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Biosimilar Testing Service Market Size by Type (2015-2020)
• 12.4 Central & South America Biosimilar Testing Service Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Charles River Laboratories International
  • 13.1.1 Charles River Laboratories International Company Details
  • 13.1.2 Charles River Laboratories International Business Overview and Its Total Revenue
  • 13.1.3 Charles River Laboratories International Biosimilar Testing Service Introduction
  • 13.1.4 Charles River Laboratories International Revenue in Biosimilar Testing Service Business (2015-2020))
  • 13.1.5 Charles River Laboratories International Recent Development
• 13.2 Merck
  • 13.2.1 Merck Company Details
  • 13.2.2 Merck Business Overview and Its Total Revenue
  • 13.2.3 Merck Biosimilar Testing Service Introduction
  • 13.2.4 Merck Revenue in Biosimilar Testing Service Business (2015-2020)
  • 13.2.5 Merck Recent Development
• 13.3 PPD
  • 13.3.1 PPD Company Details
  • 13.3.2 PPD Business Overview and Its Total Revenue
  • 13.3.3 PPD Biosimilar Testing Service Introduction
  • 13.3.4 PPD Revenue in Biosimilar Testing Service Business (2015-2020)
  • 13.3.5 PPD Recent Development
• 13.4 LAB Holdings
  • 13.4.1 LAB Holdings Company Details
  • 13.4.2 LAB Holdings Business Overview and Its Total Revenue
  • 13.4.3 LAB Holdings Biosimilar Testing Service Introduction
  • 13.4.4 LAB Holdings Revenue in Biosimilar Testing Service Business (2015-2020)
  • 13.4.5 LAB Holdings Recent Development
• 13.5 Eurofins Scientific
  • 13.5.1 Eurofins Scientific Company Details
  • 13.5.2 Eurofins Scientific Business Overview and Its Total Revenue
  • 13.5.3 Eurofins Scientific Biosimilar Testing Service Introduction
  • 13.5.4 Eurofins Scientific Revenue in Biosimilar Testing Service Business (2015-2020)
  • 13.5.5 Eurofins Scientific Recent Development
• 13.6 Intertek
  • 13.6.1 Intertek Company Details
  • 13.6.2 Intertek Business Overview and Its Total Revenue
  • 13.6.3 Intertek Biosimilar Testing Service Introduction
  • 13.6.4 Intertek Revenue in Biosimilar Testing Service Business (2015-2020)
  • 13.6.5 Intertek Recent Development
• 13.7 SGS
  • 13.7.1 SGS Company Details
  • 13.7.2 SGS Business Overview and Its Total Revenue
  • 13.7.3 SGS Biosimilar Testing Service Introduction
  • 13.7.4 SGS Revenue in Biosimilar Testing Service Business (2015-2020)
  • 13.7.5 SGS Recent Development
• 13.8 Profacgen
  • 13.8.1 Profacgen Company Details
  • 13.8.2 Profacgen Business Overview and Its Total Revenue
  • 13.8.3 Profacgen Biosimilar Testing Service Introduction
  • 13.8.4 Profacgen Revenue in Biosimilar Testing Service Business (2015-2020)
  • 13.8.5 Profacgen Recent Development
• 13.9 Antibody Analytics
  • 13.9.1 Antibody Analytics Company Details
  • 13.9.2 Antibody Analytics Business Overview and Its Total Revenue
  • 13.9.3 Antibody Analytics Biosimilar Testing Service Introduction
  • 13.9.4 Antibody Analytics Revenue in Biosimilar Testing Service Business (2015-2020)
  • 13.9.5 Antibody Analytics Recent Development
• 13.10 Kymos Pharma Services
  • 13.10.1 Kymos Pharma Services Company Details
  • 13.10.2 Kymos Pharma Services Business Overview and Its Total Revenue
  • 13.10.3 Kymos Pharma Services Biosimilar Testing Service Introduction
  • 13.10.4 Kymos Pharma Services Revenue in Biosimilar Testing Service Business (2015-2020)
  • 13.10.5 Kymos Pharma Services Recent Development
• 13.11 Medicilon
  • 10.11.1 Medicilon Company Details
  • 10.11.2 Medicilon Business Overview and Its Total Revenue
  • 10.11.3 Medicilon Biosimilar Testing Service Introduction
  • 10.11.4 Medicilon Revenue in Biosimilar Testing Service Business (2015-2020)
  • 10.11.5 Medicilon Recent Development
• 13.12 Pacific BioLabs
  • 10.12.1 Pacific BioLabs Company Details
  • 10.12.2 Pacific BioLabs Business Overview and Its Total Revenue
  • 10.12.3 Pacific BioLabs Biosimilar Testing Service Introduction
  • 10.12.4 Pacific BioLabs Revenue in Biosimilar Testing Service Business (2015-2020)
  • 10.12.5 Pacific BioLabs Recent Development
• 13.13 Sartorius
  • 10.13.1 Sartorius Company Details
  • 10.13.2 Sartorius Business Overview and Its Total Revenue
  • 10.13.3 Sartorius Biosimilar Testing Service Introduction
  • 10.13.4 Sartorius Revenue in Biosimilar Testing Service Business (2015-2020)
  • 10.13.5 Sartorius Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer